Tumor markers in the management of patients with ovarian cancer

Cancer Treat Rev. 1995 May;21(3):215-45. doi: 10.1016/0305-7372(95)90002-0.
No abstract available

Publication types

  • Review

MeSH terms

  • Antigens, Neoplasm / analysis
  • Biomarkers, Tumor / analysis*
  • Blood Proteins / analysis
  • CA-125 Antigen / analysis
  • Carcinoembryonic Antigen / analysis
  • Diagnosis, Differential
  • Female
  • Humans
  • Lectins, C-Type*
  • Mass Screening / methods
  • Neoplasm Staging
  • Ovarian Neoplasms / diagnosis*
  • Peptides / analysis
  • Prognosis
  • Sensitivity and Specificity
  • Tissue Polypeptide Antigen
  • Trypsin Inhibitor, Kazal Pancreatic / analysis

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Blood Proteins
  • CA-125 Antigen
  • Carcinoembryonic Antigen
  • Lectins, C-Type
  • Peptides
  • Tissue Polypeptide Antigen
  • tetranectin
  • Trypsin Inhibitor, Kazal Pancreatic